Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 CAD | -1.23% | +3.90% | -10.61% |
04-11 | Oncolytics Biotech Inc. Announces the Submission of a Type C Meeting Request to the FDA | CI |
04-11 | Oncolytics Biotech Down 1.8% In US Premarket As Submits Type C Meeting Request to FDA | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.61% | 89.19M | |
+22.51% | 46.4B | |
-1.66% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.48% | 26.01B | |
-19.49% | 19.52B | |
+30.18% | 12.43B | |
-0.08% | 12.18B | |
-0.73% | 12.13B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep